{"id":"W2162070501","doi":"10.1016/s2213-2600(14)70218-8","title":"Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)","year":2014,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"National Institute for Health and Care Research; Vertex Pharmaceuticals","keywords":"Ivacaftor; Medicine; Cystic fibrosis; Adverse effect; Cystic fibrosis transmembrane conductance regulator; Internal medicine; Placebo; Exacerbation; Clinical trial; Vital capacity; Pediatrics; Lung; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001407566,0.001495601,0.002398624,0.0003510077,0.0004918784,0.001533975,0.0007167817,0.001963412,0.00296415],"category_scores_gemma":[0.001952403,0.0005897414,0.002783228,0.0003692003,0.001220449,0.001669008,0.0003038931,0.004596586,0.0009387602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007804548,"about_ca_system_score_gemma":0.001257935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001181414,"about_ca_topic_score_gemma":0.002080219,"domain_scores_codex":[0.9994141,0.0002124253,0.00003491267,0.0001153621,0.00005465286,0.0001685915],"domain_scores_gemma":[0.9986246,0.0003494518,0.0003185089,0.0001430665,0.0001009307,0.0004633716],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9010727,0.01544738,0.006255954,0.000464315,0.001564649,0.0001697188,0.0002144539,0.000750931,0.01294118,0.0001119727,0.00190924,0.05909746],"study_design_scores_gemma":[0.7090243,0.2647301,0.02041038,0.00006357736,0.001139558,0.0002237983,0.0001124969,0.0006281477,0.00201021,0.0001658087,0.001433402,0.00005828764],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938839,0.002946256,0.0003008106,0.0004207122,0.0001276155,0.00044353,0.0009322345,0.00008054759,0.0008643988],"genre_scores_gemma":[0.9938948,0.00142043,0.0007094879,0.0007235783,0.0002668079,0.000499373,0.001256737,0.0000263159,0.001202437],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00296415,"threshold_uncertainty_score":0.009916008,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0512044956508712,"score_gpt":0.3703018280819421,"score_spread":0.3190973324310709,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}